Tag archive for ‘Shai Novick’
OPKO
Moshe Golan On Wednesday, April 16th, 2014

Opko health turns Prolor Biologics into Israeli R&D, investment arm

– Chairman Phillip Frost: We have big plans for Opko Biologics. – Opko Health Inc. (NYSE: OPK; TASE: OPK) has renamed Prolor Biotech, which it acquired for $480 million a year ago, as Opko More...

Wordpress site Developed by Fixing WordPress Problems